anmelden
Analysen von Richard Vosser
| 27.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 24.07.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 24.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 22.07.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 21.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.07.26 | Bayer Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 14.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.07.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 06.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 25.06.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 22.06.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 22.06.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 09.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.06.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 26.05.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 14.05.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.05.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 13.05.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 12.05.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 08.05.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 06.05.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 06.05.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 05.05.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.05.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 05.05.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 01.05.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 29.04.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 28.04.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 23.04.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 20.04.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 10.04.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 10.04.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 07.04.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 07.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |